Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOLD study of odevixibat in children with biliary atresia after Kasai portoenterostomy
CTR20212025Phase 3Completed
- Sponsor
- Albireo Pharma
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of odevixibat in biliary atresia, sponsored by Albireo Pharma. Started Feb 2022; status: completed.
02
Drugs
odevixibat
03
Conditions
biliary atresia
Beyond the preview
Go deeper on CTR20212025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212025.